Literature DB >> 9721390

Impact of a dedicated intravenous therapy team on nosocomial bloodstream infection rates.

P A Meier1, M Fredrickson, M Catney, M D Nettleman.   

Abstract

BACKGROUND: Meticulous care of intravenous catheters could be expected to minimize associated nosocomial bloodstream infections, but care is often suboptimal.
METHODS: To examine the ostensible benefits of a professional, dedicated intravenous therapy team, we compared the secular trends in nosocomial bloodstream infections before and after such a team was established.
RESULTS: After the introduction of the team at the Veterans Administration Medical Center, the rate of primary nosocomial bloodstream infection decreased by 35% (1.1 to 0.7 infections/1000 patients-days, P < .01), including a 51% decrease in bloodstream infections caused by Staphylococcus aureus (P < .01). The excess cost of the team was $252,000 per year. The excess costs per life saved and infection prevented were projected to be $53,000 and $14,000, respectively.
CONCLUSIONS: The introduction of a dedicated intravenous therapy team was associated with a significant reduction in nosocomial bloodstream infections. Further work is needed to maximize the cost-benefit ratio of this intervention.

Entities:  

Mesh:

Year:  1998        PMID: 9721390     DOI: 10.1016/s0196-6553(98)70033-1

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  3 in total

1.  Effect of a closed drug-delivery system on the incidence of nosocomial and catheter-related bloodstream infections in infants.

Authors:  P D Reiter; K Novak; R J Valuck; A A Rosenberg; D Fish
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

Review 2.  Vascular access specialist teams for device insertion and prevention of failure.

Authors:  Peter J Carr; Niall S Higgins; Marie L Cooke; Gabor Mihala; Claire M Rickard
Journal:  Cochrane Database Syst Rev       Date:  2018-03-20

Review 3.  Reducing the risk of infection associated with vascular access devices through nanotechnology: a perspective.

Authors:  Li Zhang; Samantha Keogh; Claire M Rickard
Journal:  Int J Nanomedicine       Date:  2013-11-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.